SLC5A2 and Hypoglycemia: A prior study [11] has reported that the occurrence of events due to SGLT2 side effects other than HF, such as dehydration, hypoglycemia, and ketoacidosis, is increased in frail conditions but did not differ between patients with and without treatment with SGLT2 inhibitors.